tykhr
sign in
free sign up
Vanda Pharmaceuticals Inc
Biotechnology
Healthcare
VNDA
58.26 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
4.06
52 week high
6.50
high
4.19
52 week low
4.13
low
3.85
growth
-19.18 %
previous Close
4.14
P/E ratio
market cap
315 M
div yield
0
usd
Sep 2024
qoq
revenue
47.65 M
-5.59 %
net incoming
-5.32 M
-17.84 %
eps
0.00 %
-12.50 %
eps surprise
43.75 %
net profit margin
-11.17 %
-2.00 %
operating incoming
-11.00 M
-8.42 %
net change in cash
-2.46 M
88.94 %
cash on hand
100.50 M
-2.39 %
cost of revenue
2.55 M
-43.12 %
top